Teleflex

TFX US Health Care Health Care Equipment
S&P 600
$130.99
-0.77%
Delayed · cached 15 min

Fair value analysis

TFX
Teleflex
Health CareHealth Care Equipment
$130.99
Close used for this calculation
$31.36Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
28/100
Profitability4/25
Returns1/25
Balance Sheet18/25
Efficiency5/25
Growth6/25
Weak
Quality radar
28Prof.4/25Ret.1/25Eff.5/25B.Sht18/25Growth6/25

Consensus fair value

$31.36
Above FV
▼ -76.1% against the close used
Model range $0.46 – $51.40
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$0.46Fair value$31.36Bull$51.40
FairClose
52-week traded range
52W low $100.3452W high $142.05

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Teleflex closed at $130.99, 317.7% above the consensus fair value of $31.36 drawn from 3 valuation models.

Financial DNA score 28/100 — Weak.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$0.46
-99.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=7.2%, r=10%, tg=3%, n=10yr
EV/EBITDA
$31.36
-76.1%
(EBITDA × 13.6x − Net Debt) ÷ Shares
EBITDA=296.11M
Dividend Discount (DDM)
$51.40
-60.8%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=1.36, r=10%, g=7.2%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.